{
  "ticker": "EW",
  "year": 2023,
  "quarter": 3,
  "last_updated": "2025-04-15T16:12:15.965878",
  "count": 49,
  "transactions": [
    {
      "id": 131791,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-09-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 181654,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-09-29",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 131810,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-09-14",
      "transaction_shares": "4500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "44002.6931"
    },
    {
      "id": 131889,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2023-09-14",
      "transaction_shares": "7262.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "7262.0000"
    },
    {
      "id": 131949,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-09-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 181674,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-09-14",
      "transaction_shares": "4500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "44002.6931"
    },
    {
      "id": 181759,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Markowitz Wayne",
      "reporting_owner_cik": "0001991414",
      "reporting_owner_position": "GM & SVP, Surgical",
      "transaction_date": "2023-09-14",
      "transaction_shares": "7262.0000",
      "transaction_price": "0.0000",
      "transaction_type": "A",
      "shares_after_transaction": "7262.0000"
    },
    {
      "id": 181824,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-09-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 131916,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-09-08",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "39813.5710"
    },
    {
      "id": 181788,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-09-08",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "39813.5710"
    },
    {
      "id": 131859,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-09-06",
      "transaction_shares": "8500.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "32450.0000"
    },
    {
      "id": 181724,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-09-06",
      "transaction_shares": "8500.0000",
      "transaction_price": "59.2567",
      "transaction_type": "M",
      "shares_after_transaction": "32450.0000"
    },
    {
      "id": 131866,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-09-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 181732,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-09-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "33835.8200"
    },
    {
      "id": 131924,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-08-31",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 131931,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-31",
      "transaction_shares": "49766.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "4485.8200"
    },
    {
      "id": 181797,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-08-31",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 181806,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-31",
      "transaction_shares": "49766.0000",
      "transaction_price": "0.0000",
      "transaction_type": "G",
      "shares_after_transaction": "4485.8200"
    },
    {
      "id": 131805,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-08-29",
      "transaction_shares": "1500.0000",
      "transaction_price": "76.6936",
      "transaction_type": "S",
      "shares_after_transaction": "23950.0000"
    },
    {
      "id": 181668,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Chopra Daveen",
      "reporting_owner_cik": "0001740963",
      "reporting_owner_position": "CVP, TMTT",
      "transaction_date": "2023-08-29",
      "transaction_shares": "1500.0000",
      "transaction_price": "76.6936",
      "transaction_type": "S",
      "shares_after_transaction": "23950.0000"
    },
    {
      "id": 131840,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-08-14",
      "transaction_shares": "4500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "44002.6931"
    },
    {
      "id": 131847,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-08-14",
      "transaction_shares": "6421.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "220214.7137"
    },
    {
      "id": 181705,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-08-14",
      "transaction_shares": "4500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "44002.6931"
    },
    {
      "id": 181712,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-08-14",
      "transaction_shares": "6421.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "220214.7137"
    },
    {
      "id": 131849,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-10",
      "transaction_shares": "3303.0000",
      "transaction_price": "78.8703",
      "transaction_type": "S",
      "shares_after_transaction": "26980.0000"
    },
    {
      "id": 181714,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "STONE HEISZ LESLIE",
      "reporting_owner_cik": "0001235408",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-10",
      "transaction_shares": "3303.0000",
      "transaction_price": "78.8703",
      "transaction_type": "S",
      "shares_after_transaction": "26980.0000"
    },
    {
      "id": 131943,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-08-09",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "39813.5710"
    },
    {
      "id": 181818,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-08-09",
      "transaction_shares": "5000.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "39813.5710"
    },
    {
      "id": 131885,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-07",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "83601.8200"
    },
    {
      "id": 181755,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-08-07",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "83601.8200"
    },
    {
      "id": 131818,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-07-31",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 131856,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2023-07-31",
      "transaction_shares": "2558.6207",
      "transaction_price": "83.5389",
      "transaction_type": "I",
      "shares_after_transaction": "47111.4942"
    },
    {
      "id": 181682,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Ullem Scott B.",
      "reporting_owner_cik": "0001446989",
      "reporting_owner_position": "CVP, Chief Financial Officer",
      "transaction_date": "2023-07-31",
      "transaction_shares": "7255.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "26503.0000"
    },
    {
      "id": 181721,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Zovighian Bernard J",
      "reporting_owner_cik": "0001665141",
      "reporting_owner_position": "CEO",
      "transaction_date": "2023-07-31",
      "transaction_shares": "2558.6207",
      "transaction_price": "83.5389",
      "transaction_type": "I",
      "shares_after_transaction": "47111.4942"
    },
    {
      "id": 88411,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-07-14",
      "transaction_shares": "3500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "43002.6931"
    },
    {
      "id": 88459,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-07-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 131890,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-07-14",
      "transaction_shares": "3500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "43002.6931"
    },
    {
      "id": 131944,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-07-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 181760,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "BOBO DONALD E JR",
      "reporting_owner_cik": "0001196661",
      "reporting_owner_position": "CVP,Strategy/Corp Development",
      "transaction_date": "2023-07-14",
      "transaction_shares": "3500.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "43002.6931"
    },
    {
      "id": 181819,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Wood Larry L",
      "reporting_owner_cik": "0001440660",
      "reporting_owner_position": "Global President TAVR & Surg",
      "transaction_date": "2023-07-14",
      "transaction_shares": "8660.0000",
      "transaction_price": "45.2767",
      "transaction_type": "M",
      "shares_after_transaction": "222453.7137"
    },
    {
      "id": 88383,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-07-07",
      "transaction_shares": "252.0000",
      "transaction_price": "90.4600",
      "transaction_type": "F",
      "shares_after_transaction": "34813.5710"
    },
    {
      "id": 88403,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-07-07",
      "transaction_shares": "81.0000",
      "transaction_price": "90.4600",
      "transaction_type": "F",
      "shares_after_transaction": "173583.7785"
    },
    {
      "id": 131857,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-07-07",
      "transaction_shares": "252.0000",
      "transaction_price": "90.4600",
      "transaction_type": "F",
      "shares_after_transaction": "34813.5710"
    },
    {
      "id": 131880,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-07-07",
      "transaction_shares": "81.0000",
      "transaction_price": "90.4600",
      "transaction_type": "F",
      "shares_after_transaction": "173583.7785"
    },
    {
      "id": 181722,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Szyman Catherine M.",
      "reporting_owner_cik": "0001438538",
      "reporting_owner_position": "CVP, Critical Care",
      "transaction_date": "2023-07-07",
      "transaction_shares": "252.0000",
      "transaction_price": "90.4600",
      "transaction_type": "F",
      "shares_after_transaction": "34813.5710"
    },
    {
      "id": 181749,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "Lemercier Jean-Luc M",
      "reporting_owner_cik": "0001710625",
      "reporting_owner_position": "CVP, EMEACLA and JAPAC",
      "transaction_date": "2023-07-07",
      "transaction_shares": "81.0000",
      "transaction_price": "90.4600",
      "transaction_type": "F",
      "shares_after_transaction": "173583.7785"
    },
    {
      "id": 88442,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "83601.8200"
    },
    {
      "id": 131923,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "83601.8200"
    },
    {
      "id": 181796,
      "issuer_name": "Edwards Lifesciences Corp",
      "reporting_owner": "MUSSALLEM MICHAEL A",
      "reporting_owner_cik": "0001204551",
      "reporting_owner_position": null,
      "transaction_date": "2023-07-05",
      "transaction_shares": "29350.0000",
      "transaction_price": "36.7500",
      "transaction_type": "M",
      "shares_after_transaction": "83601.8200"
    }
  ]
}